Cardio Diagnostics shareholders approve director slate and key proposals at annual meeting
PositiveFinancial Markets

Cardio Diagnostics recently held its annual meeting where shareholders approved a new slate of directors and key proposals aimed at enhancing the company's strategic direction. This approval is significant as it reflects the confidence shareholders have in the leadership and future plans of the company, which is crucial for its growth and innovation in the healthcare sector.
— Curated by the World Pulse Now AI Editorial System